Aled Charles

Process Development Director at Rentschler Biopharma

Speaker

Aled Charles is the Process Development Director of Rentschler Biopharma’s ATMP business, leading the process and analytical development teams to develop analytics and processes for clients to bring advanced therapies to patients. Aled has over twenty years of experience in the biotech and cell and gene therapy field, spanning roles in manufacturing, process development and senior leadership.

Prior to Rentschler Biopharma, Aled worked for AstraZeneca for twelve years in the biopharmaceutical development department focusing on the purification scale up and tech transfer of assets through the business ranging from biologics, peptides and viral vectors. Aled led the early material supply team and was also responsible for the global IgG purification platform. Aled has also held CMC roles working with exosomes and bacteriophage where he had responsibility for developing and scaling up processes for clinical production and has supported successful clinical manufacturing campaigns.

Aled holds a BSc degree in Chemistry from the University of Bristol.